Lalitha Venkataraman
Overview
Explore the profile of Lalitha Venkataraman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
93
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cho H, Schulz P, Venkataraman L, Caselli R, Sierks M
Int J Mol Sci
. 2022 Dec;
23(24).
PMID: 36555310
Blood-based biomarkers are needed for the early diagnosis of Alzheimer's disease (AD). We analyzed longitudinal human plasma samples from AD and control cases to identify biomarkers for the early diagnosis...
2.
Chen S, Acosta D, Li L, Liang J, Chang Y, Wang C, et al.
Acta Neuropathol
. 2022 Apr;
143(5):547-569.
PMID: 35389045
Selective neuronal vulnerability to protein aggregation is found in many neurodegenerative diseases including Alzheimer's disease (AD). Understanding the molecular origins of this selective vulnerability is, therefore, of fundamental importance. Tau...
3.
Venkataraman L, Fair S, McElroy C, Hester M, Fu H
Stem Cell Rev Rep
. 2020 Nov;
18(2):696-717.
PMID: 33180261
Many neurodegenerative diseases (NDs) such as Alzheimer's disease, Parkinson's disease, frontotemporal dementia, amyotrophic lateral sclerosis and Huntington's disease, are characterized by the progressive accumulation of abnormal proteinaceous assemblies in specific...
4.
Li L, Venkataraman L, Chen S, Fu H
Neurosci Biobehav Rev
. 2020 Sep;
118:775-783.
PMID: 32949681
L.P. Li, L. Venkataraman, S. Chen, and H.J. Fu. Function of WFS1 and WFS2 in the Central Nervous System: Implications for Wolfram Syndrome and Alzheimer's Disease. NEUROSCI BIOBEHAV REVXXX-XXX,2020.-Wolfram syndrome...
5.
Venkataraman L, He P, Khan G, Harris B, Sierks M
BMC Neurosci
. 2020 Sep;
21(1):36.
PMID: 32887544
Background: Frontotemporal dementia (FTD) is the second leading cause of early onset dementia following Alzheimer's disease. It involves atrophy of the frontal and temporal regions of the brain affecting language,...
6.
Venkataraman L, He P, Schulz P, Sierks M
Neurobiol Aging
. 2020 Jun;
94:7-14.
PMID: 32497877
Reagents that can selectively recognize specific toxic tau variants associated with onset and progression of Alzheimer's disease (AD) and other tauopathies can be effective diagnostic and therapeutic tools. We utilized...
7.
Williams S, Venkataraman L, Tian H, Khan G, Harris B, Sierks M
J Vis Exp
. 2015 Mar;
(96).
PMID: 25742170
Because protein variants play critical roles in many diseases including TDP-43 in Amyotrophic Lateral Sclerosis (ALS), alpha-synuclein in Parkinson's disease and beta-amyloid and tau in Alzheimer's disease, it is critically...